The PowerShares Dynamic Biotechnology & Genome Portfolio (NYSEArca: PBE) is up 56.9% year-to-date.
PBE tries to reflect the performance of the Dyanmic Biotechnology & Genome Intellidex Index, which is comprised of biotech and genome companies that engage in the research, development, manufacture and marketing and distribution of various biotech products, services and processes and companies that benefit from advances in biotech and genetic engineering. The Fund’s underlying index is fundamentally weighted and selects components based on price momentum, earnings momentum, quality, management action and value.
Next page: #7 PowerShares Gold Dragon China Portfolio